159 related articles for article (PubMed ID: 30655793)
1. Clinical significance of reduced GPRC5A expression in surgically resected non-small cell lung cancer.
Jin E; Wang W; Fang M; Wang W; Xie R; Zhou H; Ye J; Xu R; Ma S
Oncol Lett; 2019 Jan; 17(1):502-507. PubMed ID: 30655793
[TBL] [Abstract][Full Text] [Related]
2. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
[TBL] [Abstract][Full Text] [Related]
3. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
4. G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.
Fujimoto J; Kadara H; Garcia MM; Kabbout M; Behrens C; Liu DD; Lee JJ; Solis LM; Kim ES; Kalhor N; Moran C; Sharafkhaneh A; Lotan R; Wistuba II
J Thorac Oncol; 2012 Dec; 7(12):1747-1754. PubMed ID: 23154545
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
6.
Lin Y; Wang Y; Xue Q; Zheng Q; Chen L; Jin Y; Huang Z; Li Y
Transl Lung Cancer Res; 2024 May; 13(5):1010-1031. PubMed ID: 38854942
[TBL] [Abstract][Full Text] [Related]
7. GPRC5a suppresses the proliferation of non-small cell lung cancer under wild type p53 background.
Er J; Chao L; Yiwei L; Feng X; Fei Z; Kan W; Ruifei X
Exp Lung Res; 2020 Sep; 46(7):226-233. PubMed ID: 32410473
[No Abstract] [Full Text] [Related]
8. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer suppressor gene GPRC5A mediates p53 activity in non‑small cell lung cancer cells in vitro.
Jin E; Wang W; Fang M; Wang L; Wu K; Zhang Y; Zhang S; Ma S
Mol Med Rep; 2017 Nov; 16(5):6382-6388. PubMed ID: 28849235
[TBL] [Abstract][Full Text] [Related]
10. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
11. Low claudin-6 expression correlates with poor prognosis in patients with non-small cell lung cancer.
Wang Q; Zhang Y; Zhang T; Han ZG; Shan L
Onco Targets Ther; 2015; 8():1971-7. PubMed ID: 26261421
[TBL] [Abstract][Full Text] [Related]
12. AP‑4 predicts poor prognosis in non‑small cell lung cancer.
Gong H; Han S; Yao H; Zhao H; Wang Y
Mol Med Rep; 2014 Jul; 10(1):336-40. PubMed ID: 24804973
[TBL] [Abstract][Full Text] [Related]
13. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
[TBL] [Abstract][Full Text] [Related]
14. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
15. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
16. Tazarotene-induced gene 2 is associated with poor survival in non-small cell lung cancer.
Cai Q; Huang Z; Qi L; Wang T; Shen Y; Huang J
Oncol Lett; 2016 Oct; 12(4):2680-2685. PubMed ID: 27698842
[TBL] [Abstract][Full Text] [Related]
17. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014 Apr; ():. PubMed ID: 24712844
[TBL] [Abstract][Full Text] [Related]
18. Expression of the recepteur d'originenantais receptor tyrosine kinase in non-small cell lung cancer and its clinical significance.
Han WL; Li WD; Hu J; Rusidanmu A; Chen LF; Shen L; Zheng SS
Chin Med J (Engl); 2012 Mar; 125(6):1110-4. PubMed ID: 22613539
[TBL] [Abstract][Full Text] [Related]
19. The expression of the circadian gene TIMELESS in non-small-cell lung cancer and its clinical significance.
Zhang Y; Peng X; Yang H; Zhao H; Xia B; You Y
Int J Clin Exp Pathol; 2020; 13(9):2297-2304. PubMed ID: 33042334
[TBL] [Abstract][Full Text] [Related]
20. Activating transcription factor 2 expression mediates cell proliferation and is associated with poor prognosis in human non-small cell lung carcinoma.
You Z; Zhou Y; Guo Y; Chen W; Chen S; Wang X
Oncol Lett; 2016 Jan; 11(1):760-766. PubMed ID: 26870280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
